Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin for Ovarian Function Preservation in Breast Cancer
NCT00429403Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2006
- Primary completion
- Jul 2010
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of goserelin in primary ovarian insufficiency (POI), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2006; status: terminated.
02
Drugs
goserelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00429403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429403.